Wegovy: the weekly injection, the daily pill, side effects and the coupon
This semaglutide medicine for weight management comes as a once-weekly injection, now with a 7.2 mg strength, and as a daily tablet. An AM Rx provider reads your health history online, and our insurance team handles the prior authorization for brand-name Wegovy.
- Average loss of 14.9% of body weight at 68 weeks on 2.4 mg; placebo 2.4%1
- A $25 monthly copay is possible when your plan covers Wegovy*
- No appointment needed to begin
- Eligible adults in all 50 states and Washington, DC
Wegovy has a boxed warning. Read the safety information first.
What is Wegovy approved for?
Three things. Alongside a lower-calorie diet and more activity, the injection is FDA-approved for losing excess weight and keeping it off: in adults and children aged 12 and up who have obesity, and in adults who have overweight plus a weight-related condition. Its other approvals: reducing major cardiovascular events in adults who have cardiovascular disease as well as obesity or overweight, and treating the liver disease MASH.2
Is compounded semaglutide the same thing?
No. A pharmacy prepares compounded semaglutide for one patient’s prescription. It is not FDA-approved, and no FDA review of its safety, effectiveness or quality takes place.3 The trial figures here were measured with Wegovy itself. See our semaglutide page.
*Only when your plan covers Wegovy, which your insurer decides. Approval is never guaranteed. †From $106 a month when three months are ordered together, or $199 for one month, shipping included. Not FDA-approved. Membership ($39 in month one, $135 monthly afterward) is a separate charge.
Safety summary: The boxed warning on Wegovy is about thyroid C-cell tumors. The drug is off limits for anyone with MEN 2, and for anyone whose own or family medical history includes medullary thyroid carcinoma. Full safety information.
Wegovy weight loss results: 14.9% on average in the STEP 1 trial
STEP 1 tested the 2.4 mg injection in 1,961 adults who had obesity or overweight but not diabetes. All received lifestyle counseling. At week 68 the 2.4 mg group weighed 14.9% less on average. For placebo the figure was 2.4%.1
Two later trials tested the newer options: 18.7% at 72 weeks with the 7.2 mg injection, and 13.6% at 64 weeks with the 25 mg tablet.4,5 The trial table sets them side by side.
Simple arithmetic on trial averages, not a prediction. The trials differed in length, and some participants lost far more than average, others far less.
What Wegovy is, and how it differs from compounded semaglutide
One is a brand-name medicine with FDA approval. The other shares the active ingredient but not the approval. An AM Rx provider may prescribe either, when appropriate.
| Feature | Brand Wegovy | Compounded semaglutide |
|---|---|---|
| Made by | Novo Nordisk | A partner pharmacy, one prescription at a time |
| FDA-approved | Yes: weight management, cardiovascular risk reduction, MASH2 | No. Safety, effectiveness and quality are not reviewed by the FDA3 |
| Studied in the trials shown here | Yes | No |
| How you receive it | Through the pharmacy you pick | Delivered to your home with supplies, typically 2 to 9 business days after the prescription |
| Medication price | Copay possibly $25/mo with coverage; otherwise Novo Nordisk’s self-pay prices | $199 for one month, or three months together from $106/mo. Shipping included |
| AM Rx membership | $39 in month one, $135 monthly after. Medication costs extra. | |
How Wegovy works
Semaglutide imitates GLP-1, a hormone your gut releases. The drug is 94% identical to the human hormone and binds to albumin in the blood, which stretches its half-life to roughly a week.2
It works on GLP-1 receptors in the parts of the brain that govern appetite, so calorie intake falls. Stomach emptying slows too. An injected dose is 89% absorbed; a swallowed tablet, 1% to 2%.2 For the hormone itself, see what GLP-1 means.
Key dates and evidence
- June 4, 2021: injection approved for adults whose BMI is at least 30, or at least 27 alongside a weight-related condition.6
- December 22, 2025: tablet approved.7 On sale since January 5, 2026.8
- March 19, 2026: 7.2 mg injection, Wegovy HD, approved.9
- SELECT trial, 17,604 adults: major cardiovascular events struck 6.5% on Wegovy and 8.0% on placebo.10
Wegovy clinical trial results by dose
| Trial | Wegovy dose | Weeks | Average weight change | Placebo |
|---|---|---|---|---|
| STEP 1 (1,961 adults)1 | 2.4 mg weekly | 68 | −14.9% | −2.4% |
| STEP UP (1,407 adults)4 | 7.2 mg weekly | 72 | −18.7% | −3.9% |
| OASIS 4 (307 adults)5 | 25 mg tablet daily | 64 | −13.6% | −2.2% |
These trials excluded people with diabetes. In adults with type 2 diabetes, a separate trial of the 2.4 mg injection found a smaller loss, 9.6%. By the label’s analysis of STEP 1, 83.5% of the Wegovy group lost 5% or more, versus 31.1% for placebo.2 Averages do not predict one person’s result.
The Wegovy pill: who it is for, doses, rules, results and price
Wegovy tablets contain semaglutide and are swallowed once daily. FDA approval came on December 22, 2025, for adults only. It covers weight reduction for adults who have obesity, or overweight together with a weight-related condition, and lower cardiovascular risk for adults with established cardiovascular disease plus obesity or overweight.2,7
The tablet has no MASH approval and none for under-18s.2 It is an FDA-approved form of Wegovy, and which form suits a patient, if any, is the prescriber’s call.
Wegovy pill dose steps and self-pay prices
| Days of treatment | Tablet strength | Stage | Self-pay price, bottle of 30 |
|---|---|---|---|
| 1 to 30 | 1.5 mg | Start | $149 |
| 31 to 60 | 4 mg | Step 2 | $199 |
| 61 to 90 | 9 mg | Step 3 | $299 |
| 91 and beyond | 25 mg | Maintenance | $299 |
Dose steps: prescribing information.2 Prices: Novo Nordisk, November 2026, one bottle being a month’s supply.11 If 25 mg cannot be tolerated, the label suggests considering the 1.7 mg injection instead.2
Taking Wegovy tablets: four rules
- As soon as you wake, stomach empty.
- With plain water, 4 ounces or less.
- Whole: never split, crushed, chewed or dissolved.
- Then nothing else by mouth for 30 minutes: no food, drinks or other medicines.
One tablet daily is the limit, and a forgotten dose is skipped. Keep the bottle dry at 68°F to 77°F. Mention levothyroxine to your prescriber: the tablet raised exposure to it by 33% in a study.2
Wegovy pill results against placebo
OASIS 4 assigned 205 adults to the 25 mg tablet and 102 to placebo; none had diabetes. Average weight change at week 64: −13.6% versus −2.2%.5 In the label’s analysis, 27.9% of tablet takers lost a fifth of their weight or more, against 3.1% for placebo.2
No trial has put the tablet and the injection head to head. According to the label, semaglutide blood levels from 25 mg tablets and 2.4 mg injections are similar in people without type 2 diabetes. Tablets give lower levels when a person has type 2 diabetes, and more variable levels in every group. Weight loss with tablets was not studied in adults who have type 2 diabetes.2
Wegovy pill vs injection
| Feature | TabletDaily | InjectionWeekly |
|---|---|---|
| Approved for | Adults | Ages 12 and up |
| Maintenance dose | 25 mg daily | 2.4 mg weekly (1.7 mg is allowed); 7.2 mg for some adults |
| If you miss one | Skip it | Follow the 48-hour rule under dosing |
| While breastfeeding | Not recommended | No human data |
| Self-pay per month | $149 to $299 | $349, or $399 at 7.2 mg |
Wegovy label;2 Novo Nordisk prices as of November 2026.11
Switching between Wegovy pill and injection
The label covers both directions. Leaving the 2.4 mg injection, a patient waits one week after the final shot and then starts 25 mg tablets. Leaving the 25 mg tablet, the 2.4 mg injection begins the following day (1.7 mg if the tablet was poorly tolerated). For people with type 2 diabetes who need more weight loss than the 25 mg tablet gives, it suggests considering the 1.7 mg injection. A prescriber must direct any switch.2
Getting Wegovy online: how AM Rx works
The whole process runs through your AM Rx account or the app, with no clinic visit.
1. Fill in the health intake
Questions cover your medical history, current medicines, weight and past attempts. Joining costs $39 for month one.

2. A provider reviews it
In 1 to 2 business days a U.S.-licensed, board-certified physician or nurse practitioner reads your answers and writes back by secure message. They prescribe only if the medicine is appropriate and nothing in the safety information rules it out.

3. We handle the prior authorization
For brand-name Wegovy, our coordinators send the request to your insurer. Expect an answer in 2 to 14 business days in most cases. After a denial they can resubmit; three requests is the maximum. The decision belongs to the insurer.

4. The prescription is filled
Brand-name Wegovy goes to whichever pharmacy you name. Should your plan refuse to cover it, your provider may talk through compounded semaglutide, sent from a partner pharmacy. Not FDA-approved: the FDA does not check its safety, effectiveness or quality.

5. Doses rise with support
The injection dose increases four times on the way to 2.4 mg at week 17, and side effects tend to appear around those steps. Message your provider at any point. A coach is assigned to you, and a monthly video or phone visit is yours if you want it.


What AM Rx membership includes
Month one is $39 and every month after is $135. You can cancel in the portal at any time, and HSA or FSA cards work.
- A licensed provider’s review, plus a prescription if appropriate
- Prior authorizations filed by our insurance coordination team
- Secure messaging with provider and care team, without limits
- Monthly visits by video or phone, if wanted
- Your own weight loss coach, the app and the portal
Medication is charged separately. A prior authorization stays active only while your membership does.
Get StartedWegovy side effects and how often they happen
Nausea tops the list. In weight trials it was reported by 44% of adults who took 2.4 mg injections and 16% who took placebo. Counting every stomach or bowel complaint, the figures were 73% and 47%.2
| Side effect | Wegovy 2.4 mg | Placebo | Gap, in points |
|---|---|---|---|
| Nausea | 44% | 16% | 28 |
| Vomiting | 24% | 6% | 18 |
| Diarrhea | 30% | 16% | 14 |
| Constipation | 24% | 11% | 13 |
| Stomach pain | 20% | 10% | 10 |
| Belching | 7% | under 1% | 6 to 7 |
| Tiredness | 11% | 5% | 6 |
| Indigestion | 9% | 3% | 6 |
| Headache | 14% | 10% | 4 |
| Dizziness | 8% | 4% | 4 |
| Heartburn | 5% | 3% | 2 |
| Hair loss | 3% | 1% | 2 |
From 2,116 adults on Wegovy and 1,261 on placebo across weight-management trials, ordered by the gap between the groups.2
Easing an upset stomach
- Small meals, more often: a light breakfast, then something every 3 to 4 hours.12
- During early nausea, cut back on fatty and high-fiber foods.12
- For constipation, raise fiber gradually and drink enough fluids.12
Seek medical help immediately if you have
- Severe, lasting stomach pain, with or without vomiting, that may spread to your back (possible pancreatitis).
- Upper stomach pain along with fever, yellowing skin or eyes, or pale, clay-like stools (possible gallbladder disease).
- Swelling in the face, lips, tongue or throat; problems breathing or swallowing; a severe rash.
- Sudden vision loss in one eye.
Report a neck lump, lasting hoarseness or trouble swallowing to your provider. The boxed warning explains why.
Do Wegovy side effects go away?
Usually. In a published analysis of 2.4 mg trials, 98.1% of stomach and bowel side effects were mild to moderate, they were temporary, and they clustered during or soon after dose increases.13 Even so, 6.8% of adults on the injection quit over side effects (placebo: 3.2%). For the tablet, 6.9% and 5.9%.2
Are the Wegovy pill’s side effects different?
Barely. Per the label, common side effects with the tablet matched the injection’s in type and frequency. Skin sensation changes affected 5% of tablet takers and nobody on placebo.2
Side effects of the 7.2 mg dose
| Side effect | Placebo | 2.4 mg | 7.2 mg |
|---|---|---|---|
| Nausea | 13% | 35% | 39% |
| Vomiting | 6% | 16% | 22% |
| Skin sensation changes | 0% | 6% | 22% |
| Constipation | 8% | 19% | 20% |
| Hair loss | 1% | 3% | 6% |
Skin sensation changes (dysesthesia) climbed steeply with dose, and 18% of those affected had not recovered by the end of the trial.2 Our GLP-1 side effects guide covers the wider drug class.
Wegovy dosing schedule for the injection
Treatment begins at 0.25 mg weekly. The dose goes up at 4-week intervals until it reaches 2.4 mg, the usual maintenance dose, at week 17. A hard-to-tolerate step may be held 4 weeks longer.2
| Starting in | Dose per week | Role |
|---|---|---|
| Week 1 | 0.25 mg | Introductory dose |
| Week 5 | 0.5 mg | Increase |
| Week 9 | 1 mg | Increase |
| Week 13 | 1.7 mg | Increase; may also serve as maintenance |
| Week 17 | 2.4 mg | Recommended maintenance |
| Later, optional | 7.2 mg | Adults only, after 4 or more weeks of tolerating 2.4 mg, when more weight loss is needed |
Source: Wegovy prescribing information.2 Your provider may go slower.
How to inject Wegovy
Keep to one weekday; the hour and meals make no difference. Inject beneath the skin of your abdomen, thigh or upper arm, changing the spot every time. Pens belong in the refrigerator, in the carton, never frozen. Each holds one dose.2
Missed a Wegovy injection?
Count the time to your next scheduled dose. Over 48 hours: inject the missed dose now. Under 48 hours: leave it out. If two or more consecutive doses are missed, call your provider first, since the label advises restarting lower.2 The schedule for Ozempic® differs: see our Ozempic dosage guide.
Wegovy coupon and cost: with insurance, without it, and through AM Rx
With commercial coverage and Novo Nordisk’s savings offer, the price of a month of Wegovy can fall to $25. Paying on your own, expect $149 to $399 depending on form and strength. That savings offer is the real “Wegovy coupon”.
| If you have | Monthly cost | Fine print |
|---|---|---|
| A commercial plan covering Wegovy | From $25 | The savings offer absorbs up to $100 of a one-month copay, $200 for two months, $300 for three. Injections and tablets both qualify.14 |
| No coverage: injection | $349; $399 at 7.2 mg | Per box of four pens. New patients starting at 0.25 mg or 0.5 mg pay $199 for fills one and two, until December 31, 2026.11 |
| No coverage: tablets | $149, $199 or $299 | By rising strength: 1.5 mg, 4 mg, then 9 mg or 25 mg. Thirty tablets a bottle.11 |
| Government coverage (Medicare, Medicaid, TRICARE, VA and others) | Savings offer barred. With Medicare, $50 via the Medicare GLP-1 Bridge if eligible | The Bridge covers Wegovy injection and tablets between July 1, 2026 and December 31, 2027, subject to prior authorization.15 |
Novo Nordisk sets these prices and can change them.
Wegovy cost with insurance
Coverage is your insurer’s decision. When brand-name Wegovy is prescribed, the prior authorization is filed by AM Rx’s insurance coordinators, and a covered copay as low as $25 monthly is possible. Try the GLP-1 insurance checker first.
The Wegovy coupon: Novo Nordisk’s savings offer
It pays up to $100 toward each month’s copay, with $25 as the floor. So an $85 copay becomes $25, while a $190 copay becomes $90. The prescription must be for a use the FDA has approved. No expiry date is listed, though Novo Nordisk may alter or stop the offer without notice.14
It excludes anyone in a federal or state program with drug benefits (Medicare, Medicaid, VA, Department of Defense, TRICARE), members of plans that use accumulator or maximizer programs, and anyone pairing it with a second coupon or a cash discount card.14
Coupon codes from other sites are something else. GoodRx’s Wegovy coupon, for example, is Novo Nordisk’s self-pay price administered by GoodRx, and it cannot be applied to a prescription billed to insurance.16 See our GoodRx Wegovy guide.
Wegovy cost without insurance
Novo Nordisk publishes self-pay prices. In November 2026 they are $349 monthly for any injection strength up to 2.4 mg, $399 for 7.2 mg, and $149, $199 or $299 for tablets.11 One introductory deal exists, and it expires December 31, 2026.
A new patient on the 0.25 mg or 0.5 mg injection pays $199, not $349, for two 28-day fills. Fill three costs $349. Who counts as “new” depends on where you fill:
| Filled at | “New” means | Cutoff |
|---|---|---|
| A retail pharmacy, using the savings offer | No Wegovy savings offer redeemed in the last 365 days | Fill by December 31, 202614 |
| Novo Nordisk home delivery | No earlier Wegovy injection fill through NovoCare, ever | Prescription written and received by December 31, 2026; shipped by January 31, 202717 |
| A pharmacy, using GoodRx | No other GoodRx coupon for Wegovy injection redeemed, ever | Fill by December 31, 202616 |
What you pay through AM Rx
- Membership: $39 in month one, $135 monthly afterward, medication excluded.
- Brand-name Wegovy: paid to your pharmacy. With coverage, copays can be as low as $25 monthly.
- Compounded semaglutide: $199 for a single month, or as little as $106 a month when you order 3 months. Shipping is included. Not FDA-approved: the FDA does not review its safety, effectiveness or quality.
- Bundle: membership plus compounded semaglutide for $217 in month one and $297 monthly afterward. Doses above the standard schedule can carry extra fees. Members found clinically ineligible get a refund.
Deadline. December 31, 2026 ends the $199 Wegovy introductory price and the current Zepbound® and Mounjaro® savings cards.18,19
NovoCare home delivery: what it does and does not do
NovoCare is the home delivery service run by Novo Nordisk. Give it a prescription and it bills your insurance or charges the self-pay price, then delivers free. It can refer you to a telehealth prescriber, yet each dose still requires a prescription.20
| Feature | AM Rx | NovoCare |
|---|---|---|
| Prescription comes from | An AM Rx provider, when treatment is appropriate | Your own clinician, or one it refers you to |
| Prior authorization | Filed by our team, up to three requests | Takes insurance or self-pay |
| When Wegovy is not covered | Provider may discuss compounded semaglutide (not FDA-approved) | Brand Wegovy at the self-pay price |
| Fee | $39, then $135 a month | No delivery charge |
NovoCare facts reflect Novo Nordisk’s site in November 2026.20 AM Rx is independent of Novo Nordisk and NovoCare.
Wegovy vs Zepbound, Ozempic and Mounjaro
Only Wegovy and Zepbound hold FDA approval for weight management. Ozempic and Mounjaro are diabetes medicines, which makes weight-loss use of them off-label.
Swipe the table sideways to see all four medicines.
| Feature | Wegovy | Zepbound | Ozempic | Mounjaro |
|---|---|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide | Semaglutide | Tirzepatide |
| Receptors targeted | GLP-1 | GIP and GLP-1 | GLP-1 | GIP and GLP-1 |
| FDA-approved uses | Weight, cardiovascular risk, MASH2 | Weight; sleep apnea with obesity21 | Type 2 diabetes and related heart and kidney risks22 | Type 2 diabetes and related cardiovascular risk23 |
| Weekly injection doses | 0.25 to 7.2 mg | 2.5 to 15 mg | 0.25 to 2 mg | 2.5 to 15 mg |
| Obesity trial result | −14.9%, 68 weeks1 | −15.0% to −20.9%, 72 weeks21 | Not approved for weight | Not approved for weight |
| Manufacturer self-pay, monthly | $349 or $399; tablets $149 to $29911 | $299 to $449 if refilled within 45 days18 | $349; $499 for 2 mg24 | From $499 with Lilly’s savings card when a commercial plan will not cover it19 |
| Savings card cap per month | $100 | $100; card ends December 31, 2026 | $100 | $150; card ends December 31, 2026 |
As of November 2026.14,18,19,24 Trial results come from different studies. None of the four cards works with government insurance.
A single trial has compared the two weight drugs directly. SURMOUNT-5 gave 751 adults with obesity, none with diabetes, the highest tolerated dose of tirzepatide or semaglutide for 72 weeks. Average weight loss: 20.2% on tirzepatide, 13.7% on semaglutide. Eli Lilly, tirzepatide’s maker, funded the open-label study.25 Wegovy, for its part, carries a cardiovascular approval and a tablet form, neither of which Zepbound has.2,21
How AM Rx members describe the program
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my AM Rx provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and AM Rx was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started AM Rx, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These reviews describe the experience of individual AM Rx members and do not promise any result. Medication is prescribed only if a licensed provider considers it appropriate.

Whether Wegovy suits you is a licensed provider’s decision
A physician or nurse practitioner licensed in your state checks your intake against Wegovy’s boxed warning and your current medicines before prescribing anything. That team also answers your messages at each dose step.
The AM Rx care team checks the medical content of this page against FDA prescribing information and published clinical trials. It is general health education and does not replace advice from your own provider.
Wegovy questions, answered
Can you get the Wegovy pill in the US yet?
Yes. Wegovy tablets won FDA approval on December 22, 2025 and went on sale on January 5, 2026.7,8 They are for adults: for weight reduction, and for cutting cardiovascular risk in adults who have heart disease along with obesity or overweight.2 Four strengths exist: 1.5, 4, 9 and 25 mg. See the Wegovy pill.
What is the right way to take Wegovy tablets?
Each morning before eating, swallow one whole tablet with plain water, 4 ounces at most. Take nothing else by mouth for the next 30 minutes, other drinks and medicines included. Never crush or split a tablet or take two in a day.2
Which works better, the Wegovy pill or the injection?
No trial has compared them directly. Separate studies reported average losses of 13.6% for the 25 mg tablet (64 weeks) and 14.9% for the 2.4 mg injection (68 weeks).1,5 The label adds that blood levels vary more with tablets and run lower when a person has type 2 diabetes.2
Which Wegovy side effects are most common?
Digestive ones. Among adults on the 2.4 mg injection in weight trials, nausea affected 44%, diarrhea 30%, vomiting and constipation 24% each, and stomach pain 20%. Placebo rates ran from 6% to 16%.2 Headache and tiredness were next. The table has more.
Is there a coupon for Wegovy?
One genuine coupon exists: the savings offer from Novo Nordisk. If your commercial plan covers Wegovy, it takes up to $100 off each monthly copay, down to a $25 minimum.14 Government-insured patients are excluded. Coupon sites such as GoodRx pass along the self-pay price instead, as our GoodRx Wegovy guide explains.
What does Wegovy cost per month if I pay cash?
In November 2026 the manufacturer’s self-pay prices are $349 for the injection at strengths up to 2.4 mg, $399 at 7.2 mg, and $149, $199 or $299 for tablets depending on strength.11 Until December 31, 2026, a new patient’s first two fills at the two lowest injection strengths cost $199 each.
What is Wegovy HD 7.2 mg?
It is a higher-strength weekly injection, FDA-approved since March 19, 2026.9 Nobody starts on it: the label reserves 7.2 mg for adults who have handled 2.4 mg for 4 weeks or longer and need to lose more.2 In STEP UP, the 7.2 mg group lost 18.7% on average, the 2.4 mg group 15.6%.4
Are Wegovy and Ozempic the same medicine?
Same ingredient, same manufacturer, different approvals. Wegovy is semaglutide for weight management, at up to 2.4 mg weekly or 7.2 mg for some adults. Ozempic is semaglutide for type 2 diabetes, capped at 2 mg weekly and not approved for weight loss.2,22 Never use both. See Ozempic and semaglutide.
Who can get Wegovy for $199?
New patients only, on the 0.25 mg or 0.5 mg injection, for two fills, until December 31, 2026. Retail pharmacies treat you as new if 365 days have passed without a Wegovy savings offer. Novo Nordisk’s home delivery and GoodRx require that you never used them for Wegovy injection before.14,16,17
Does the Wegovy savings offer work with Medicare?
It does not. Novo Nordisk bars everyone in federal or state programs with drug benefits, Medicare included.14 Medicare has its own program, the Medicare GLP-1 Bridge. From July 1, 2026 to December 31, 2027 it provides Wegovy to eligible people with Medicare drug coverage for a $50 monthly copay, after prior authorization.15
Can Wegovy make your hair fall out?
Sometimes. In trials, 3.3% of adults in the Wegovy 2.4 mg group reported hair loss, against 1% in the placebo group. Women reported it more than men, 4% against 0.9%, and at 7.2 mg the rate reached 5.8%. The label ties it to weight reduction.2
Will I regain weight after stopping Wegovy?
Regain is likely, judging by STEP 4. After 20 weeks on semaglutide, during which average loss was 10.6%, participants either continued or moved to placebo. In the following 48 weeks the continuing group lost another 7.9%. The placebo group put 6.9% back on.26 Discuss any plan to stop with your provider.
Is Wegovy safe during pregnancy or breastfeeding?
Not in pregnancy: it may harm an unborn baby. Stop when pregnancy is recognized, and 2 months or more ahead of a planned one, since semaglutide lingers for 5 to 7 weeks. Breastfeeding data are lacking for the injection. With tablets it is not recommended: their absorption enhancer or its breakdown products reach breast milk.2
Is a video call required to get Wegovy from AM Rx?
No live visit is required to start. Your online intake goes to a licensed provider, who reviews new intakes in 1 to 2 business days and answers by secure message. Members who want to talk can have a video or phone visit, included in the membership.
What does AM Rx charge, and does that include Wegovy?
AM Rx charges $39 for month one and $135 monthly afterward. Wegovy is not included: your pharmacy bills you, and a covered copay can run as low as $25 monthly. Compounded semaglutide is $199 for one month, or from $106 a month if you order 3 months. It is not FDA-approved or FDA-reviewed for safety, effectiveness or quality.
Keep reading about Wegovy and semaglutide
Important safety information
Boxed warning about thyroid C-cell tumors
Rodents given semaglutide developed thyroid C-cell tumors, more often at higher doses and with longer treatment. Whether Wegovy has this effect in people is unknown. The tumors in question include medullary thyroid carcinoma (MTC), a thyroid cancer. Wegovy must not be used by anyone who has had MTC, whose relatives have had it, or who has Multiple Endocrine Neoplasia syndrome type 2, known as MEN 2. Signs to report: swelling or a lump in the neck, difficulty swallowing, breathlessness, lasting hoarseness.2
Who should not take Wegovy
- People with MEN 2, or with MTC in their own or their family’s medical history.
- People who once reacted to semaglutide, or another Wegovy ingredient, with a serious allergy.
Tell your provider first if you
- Have had pancreatitis, gallbladder trouble or kidney disease.
- Have type 2 diabetes, above all with retinopathy, or use insulin or a sulfonylurea.
- Have severe gastroparesis. Wegovy is not recommended then.
- Expect surgery or a procedure involving general anesthesia or deep sedation.
- Are pregnant, breastfeeding or planning a pregnancy. Wegovy should stop 2 months or more before conception.
- Use another semaglutide product or another GLP-1 medicine. They must not be combined with Wegovy.
- Take oral medicines such as levothyroxine, whose absorption may change.
Possible serious side effects
- Acute pancreatitis.
- Gallstones and other gallbladder disease.
- Low blood sugar, chiefly alongside insulin or a sulfonylurea.
- Dehydration-related kidney injury after vomiting or diarrhea.
- Severe stomach and bowel reactions.
- Serious allergic reactions.
- Diabetic retinopathy complications in type 2 diabetes.
- A faster resting heart rate.
- Stomach contents entering the lungs under anesthesia or deep sedation.
On November 9, 2026 the FDA announced it is requiring all GLP-1 medicines to carry a warning about a possible increased risk of NAION, a rare eye condition causing sudden, painless and sometimes permanent vision loss in one eye. Wegovy’s label does not include it yet.2,27
Common side effects
In alphabetical order: belching, bloating, constipation, diarrhea, dizziness, gas, hair loss, headache, heartburn, low blood sugar if you have type 2 diabetes, nausea, skin sensation changes, stomach flu, stomach pain, tiredness, upset stomach and vomiting.11
This summary leaves things out and cannot replace your provider’s advice. The complete Prescribing Information and Medication Guide has the rest. Use the FDA’s MedWatch to report a side effect. For a suspected overdose, Poison Help is 1-800-222-1222.2
Sources
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Wegovy (semaglutide) injection and tablets prescribing information. Novo Nordisk. Revised June 2026. https://www.novo-pi.com/wegovy.pdf
- FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Current as of October 1, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Wharton S, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP). Lancet Diabetes Endocrinol. 2025;13(11):949-963. https://pubmed.ncbi.nlm.nih.gov/40961952/
- Wharton S, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). N Engl J Med. 2025;393(11):1077-1087. https://pubmed.ncbi.nlm.nih.gov/40934115/
- FDA. FDA approves new drug treatment for chronic weight management, first since 2014. June 4, 2021. https://content.govdelivery.com/accounts/USFDA/bulletins/2e2adc7
- Novo Nordisk. FDA approval of the Wegovy pill. News release, December 22, 2025. https://www.novonordisk-us.com/media/press-releases/wegovy-pill-fda-approval-obesity.html
- Novo Nordisk. Wegovy pill available nationwide. News release, January 5, 2026. https://www.novonordisk-us.com/media/press-releases/wegovy-pill-available-nationwide-us.html
- FDA. FDA approves fourth product under National Priority Voucher program, higher dose semaglutide. March 19, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-fourth-product-under-national-priority-voucher-program-higher-dose-semaglutide
- Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232. https://pubmed.ncbi.nlm.nih.gov/37952131/
- Novo Nordisk. What to pay for Wegovy. https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. Obesity (Silver Spring). 2025;33(8):1475-1503. https://pmc.ncbi.nlm.nih.gov/articles/PMC12304835/
- Wharton S, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg. Diabetes Obes Metab. 2022;24(1):94-105. https://pubmed.ncbi.nlm.nih.gov/34514682/
- Novo Nordisk. Wegovy savings offer terms and conditions. https://www.wegovyterms.com
- Medicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. https://www.medicare.gov/coverage/weight-loss-drugs
- GoodRx. Wegovy offer terms and conditions, administered on behalf of Novo Nordisk. September 2026. https://www.grxstatic.com/bds/wegovy-offer-terms-and-conditions.pdf
- Novo Nordisk. NovoCare home delivery terms. https://www.novocaredeliveryterms.com
- Eli Lilly and Company. Zepbound savings and self-pay options. https://zepbound.lilly.com/savings
- Eli Lilly and Company. Mounjaro savings and coverage. https://mounjaro.lilly.com/savings-coverage
- Novo Nordisk. NovoCare home delivery. https://www.novocare.com/pharmacy.html
- Zepbound (tirzepatide) prescribing information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
- Ozempic (semaglutide) injection prescribing information. Novo Nordisk. Revised May 2026. https://www.novo-pi.com/ozempic.pdf
- Mounjaro (tirzepatide) prescribing information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
- Novo Nordisk. Ozempic cost and insurance coverage. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
- Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393(1):26-36. https://pubmed.ncbi.nlm.nih.gov/40353578/
- Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity (STEP 4). JAMA. 2021;325(14):1414-1425. https://pubmed.ncbi.nlm.nih.gov/33755728/
- FDA. FDA requires safety labeling changes for GLP-1 receptor agonists due to potential increased risk of rare but serious eye condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
Reviewed by the AM Rx care team. Sources accessed and prices checked November 19, 2026.
Ask a licensed provider about Wegovy
Complete the health intake and a provider will reply, usually in 1 to 2 business days. Membership starts at $39 for month one.
Get Started